ArticleCancer2018

Telomerase reverse transcriptase promoter alterations across cancer types as detected by next-generation sequencing: A clinical and molecular analysis of 423 patients.

Maria Schwaederle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.